Clinicians' self-reported efficacy in cardiovascular prevention practice in the southeastern United States.
Future Cardiol
; 19(12): 593-604, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-37916575
ABSTRACT
Aim:
We assessed self-reported efficacy in cardiovascular prevention practice among internal medicine, family medicine, endocrinology and cardiology clinicians. Patients &methods:
We emailed a 21-item questionnaire to 956 physicians, nurse practitioners, physician assistants and pharmacists.Results:
264 clinicians responded (median age 39 years, 55% women, 47.9% specialists). Most expressed high self-efficacy in lifestyle counselling, prescribing statins, metformin, and aspirin in primary prevention, but low self-efficacy in managing specialized conditions like elevated lipoprotein(a). Compared with specialists, PCPs expressed lower self-efficacy in managing advanced lipid disorders and higher self-efficacy in prescribing sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists.Conclusion:
Self-efficacy in cardiovascular prevention varied across specialties. Future research should explore relevant provider, clinic and system level factors to optimize cardiovascular prevention.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
Sodium-Glucose Transporter 2 Inhibitors
Limits:
Adult
/
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Journal:
Future Cardiol
Journal subject:
CARDIOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
United States